期刊文献+

系统性红斑狼疮患者血脂异常危险因素分析

Analysis on correlation between systemic lupus erythematosus patients with dyslipidemia
下载PDF
导出
摘要 目的探讨血脂异常对系统性红斑狼疮患者的意义。方法选取系统性红斑狼疮患者124例,按血脂水平有无异常将患者分别设为观察组84例和对照组40例。观察2组总胆固醇(Tc)、甘油三酯(T)、高密度脂蛋白胆固醇(HDL-)、低密度脂蛋白胆固醇(LDL—L)水平,补体c3、c4水平,血沉速度,肾病、血液病变、抗核酸抗原抗体(ANA)阳性的发生情况。结果观察组患者TC、TG、LDL-L水平高于对照组,HDL-L水平低于对照组,差异均有统计学意义(P〈0.01)。观察组肾病、血液病变、ANA阳性发生率高于对照组,差异有统计学意义(P〈0.01)。观察组补体c3、c4水平低于对照组,观察组血沉速度高于对照组,差异有统计学意义(P〈0.01)。结论系统性红斑狼疮患者血脂异常作为临床参考指标,具有一定的参考价值。 Objective To investigate the correlation between systemic lupus erythematosus patients with dyslipidemia. Methods A total of 124 patients with systemic lupus erythematosus were assigned to observation group (n = 84, with dyslipidemia) and control group (n =40, without dyslipi- demia). The total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL- L), Low density lipoprotein cholesterol (LDL-L), complement C3and C4, sedimentation rate were observation , as well as incidence of nephropathy, hemopathy and nucleic acid resistant antigen anti- body (ANA) positive. Results The observation group had higher levels of TC ,TG, LDL-L and lower HDL-L compared with the control group (P 〈 0.01 ). The incidence of nephropathy, hemopathy and ANA positive were higher in observation group than that in control group (P 〈 0.01 ). the observation group had a lower level of complement C3and C4, but higher sedimentation rate compared with the control group (P 〈 0.01 ). Conclusion Dyslipidemia may be useful for as an indicator in systemic lupus erythematosus patients.
作者 顾维杰 汪池
出处 《实用临床医药杂志》 CAS 2015年第E01期62-63,共2页 Journal of Clinical Medicine in Practice
关键词 系统性红斑狼疮 血脂异常 危险因素 抗核酸抗原抗体 systemic lupus erythematosus dyslipidemia risk factors nucleic acid resistant antigen antibody
  • 相关文献

参考文献4

二级参考文献37

  • 1舒强,刘静,刘花香,李兴福.系统性红斑狼疮患者151例的生存质量及其影响因素[J].中华风湿病学杂志,2004,8(7):420-423. 被引量:25
  • 2游自立.应激对免疫功能及疾病发生的影响[J].中国心理卫生杂志,1995,9(3):140-142. 被引量:57
  • 3吕运来,贠中桥,兰炯采,孙先玲,杨波,张艳艳.红细胞无效输注回顾性初探[J].中国输血杂志,2007,20(3):220-221. 被引量:70
  • 4Mok CC, Mak A, Chu WP, et al. Long-term survival of southem Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups[J]. Medicine, 2005, 84(4): 218-24.
  • 5Mcmahon M, Hahn BH, Skaggs BJ. Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention[J]. Expert Rev Clin Immunol, 2011, 7(2): 227-41.
  • 6Roman M J, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus [J]. N Engl J Med, 2003, 349(25): 2399-406.
  • 7Peeters MA, Chizzolini C. Cardiovascular risk in autoimmune and inflammatory disorders[J]. Rev Med Suisse, 2011, 7(291): 867-71.
  • 8Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality pattern of systemic lupus erythematosus [J]. Am J Med, 1976, 60(2): 221-5.
  • 9Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus [J]. J Rhetunatol, 1999, 26(11): 2363-8.
  • 10Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study [J]. J Epidemiol, 1997, 145(5): 408-15.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部